JP Morgan Maintains Neutral on Doximity, Raises Price Target to $31

Benzinga Newsdesk www.benzinga.com Positive 63.5%

Neg 0% Neu 0% Pos 63.5%

JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:DOCS) with a Neutral and raises the price target from $26 to $31.